Hangzhou Gensciences Biopharmaceutical Co., Ltd.

Free public records show Hangzhou Gensciences Biopharmaceutical Co., Ltd. in 1 of the markets we cover. It is not a key player in our research.

[1] ClinicalTrials.gov, Studies led by Hangzhou Gensciences Biopharmaceutical Co., Ltd. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.

Public data

Free public data on Hangzhou Gensciences Biopharmaceutical Co., Ltd.

From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.

About our sources

Clinical trials

3 active studies led by Hangzhou Gensciences Biopharmaceutical Co., Ltd., of 9 in all

Source: ClinicalTrials.gov, Studies with Hangzhou Gensciences Biopharmaceutical Co., Ltd. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.

See them on ClinicalTrials.gov (opens in a new tab)

Trials over time

Studies Hangzhou Gensciences Biopharmaceutical Co., Ltd. leads, by the year they started and their phase

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4
  • No phase (devices, observational)

Source: ClinicalTrials.gov, Studies with Hangzhou Gensciences Biopharmaceutical Co., Ltd. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.

Markets where public records show them

Markets we cover where free public records show Hangzhou Gensciences Biopharmaceutical Co., Ltd.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.

Healthcare Topics

The topics of the markets Hangzhou Gensciences Biopharmaceutical Co., Ltd. is in.

All healthcare topics

Search all reports for Hangzhou Gensciences Biopharmaceutical Co., Ltd. All companies